MedPath

Research on traditional Chinese medicine preparation of clearing heat and detoxifying to treat epidemic disease and reduce the conversion from mild to severe (Anti-epidemic Special No.: 2022009).

Phase 2
Conditions
COVID-2019
Registration Number
ITMCTR2200005801
Lead Sponsor
Shenzhen Traditional Chinese Medicine Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) The mild and ordinary patients who meet the diagnostic criteria of COVID-19;
(2) 70 years old = 14 years old;
(3) did not receive other clinical studies before selection;
(4) voluntarily accepted the trial and signed the informed consent form.

Exclusion Criteria

(1) pregnant and lactating women;
(2) patients with delirium, dementia and various psychosis;
(3) patients with chronic respiratory diseases, including chronic bronchitis, bronchial asthma, chronic obstructive pulmonary disease, bronchiectasis, pulmonary fibrosis, pulmonary tuberculosis (uncured) and so on.
(4) patients with autoimmune-related diseases (psoriasis, ankylosing spondylitis, etc.) were treated with biological agents in the past month.
(5) patients with known experimental drug allergy
(6) patients with heart, liver and renal insufficiency before selection;
(7) patients with malignant tumor, blood system disease or immune deficiency;
(8) patients who were treated with glucocorticoid for a long time;
(9) patients with other diseases before selection were determined to interfere with the results of clinical trials.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ucleic acid detection negative time;The percentage of subjects who changed from mild to severe;a clinical symptom score;
Secondary Outcome Measures
NameTimeMethod
aboratory indicators;Length of hospital stay;Chest imaging changes;
© Copyright 2025. All Rights Reserved by MedPath